TCTR20130520001
Completed
N/A
A cohort of patients with high risk for cardiovascular events multicenter study .
The Heart Association of Thailand under the Royal Patronage of H.M.0 sites9,390 target enrollmentMay 20, 2013
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Atherosclerotic patients.Atherosclerotic risk patients.
- Sponsor
- The Heart Association of Thailand under the Royal Patronage of H.M.
- Enrollment
- 9390
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who are age at least 45 year old with either high atherosclerotic risk (group 1\) or established atherosclerotic cv disease (group 2\)
- •Group 1: Patients with The CORE Thailand is conducting to study the risk factors of atherosclerotic risk patients and patients with established atherosclerotic disease (coronary artery disease, cerebrovascular disease and peripheral arterial disease), the cardiovascular event rate in these population, the treatment and investigation for atherosclerotic disease greater than or equal to 3 risk factors as following:
- •1\.1 Diabetes (type 1 or 2\) or impaired fasting glucose
- •1\.2 Hypertension (BP less than140/90 mmHg or currently treated with antihypertensive agent)
- •1\.3 Chronic kidney disease stage I\-IV
- •1\.4 Dyslipidemia
- •1\.5 Smoking
- •1\.6 Male greater than or equal to 55 year old and woman greater than or equal to 65 year old
- •1\.7 family history of premature atherosclerosis
- •Group 2\. Patients with established atherosclerotic disease
Exclusion Criteria
- •1\. Patients with recent episodes of acute cariovascular event (within 3 months)
- •2\. Patients who are currently in blinded study
- •3\. Patients with life expectancy less than 3 years from other illness such as AIDS or cancer
- •4\. Patients with surgically indicated aortic aneurysm
- •5\. Patients with difficulty of follow up
- •6\.Patients who do not give consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
ong term impact of RAS inhibition on cardio-renal outcomes: a comparative trial of angiotensin converting enzyme inhibitors, angiotensin receptor blockers or combined therapy with both agents in patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.Patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.Cardiovascular - Normal development and function of the cardiovascular systemMetabolic and Endocrine - DiabetesACTRN12607000333415Consorzio Mario Negri Sud2,100
Recruiting
N/A
Elucidating the high cardiovascular disease risk in South Asians: focus on monocyte phenotype and incretin hormonesNL-OMON56245Interne Geneeskunde48
Recruiting
N/A
A study on risk of developing heart disease in patients with skin disease called psoriasis marked by red, itchy, scaly patches.CTRI/2013/08/003928Father Muller Medical College60
Not Yet Recruiting
N/A
To Stratify and Identify High Cardiovascular Risk in Rheumatoid Arthritis Patients.Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecifiedCTRI/2024/04/065707Maulana Azad Medical College
Completed
N/A
Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 AgonistsPulmonary Disease, Chronic ObstructiveNCT03405363Boehringer Ingelheim65,406